[
    [
        {
            "time": "2021-08-01",
            "original_text": "沃森生物(300142)2021年中报点评：13价销售放量符合预期 静待mRNA新冠疫苗三期临床结果",
            "features": {
                "keywords": [
                    "沃森生物",
                    "13价疫苗",
                    "mRNA新冠疫苗",
                    "三期临床"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物(300142)2021年中报点评：13价销售放量符合预期 静待mRNA新冠疫苗三期临床结果",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-09-06",
            "original_text": "北向资金追平年内最长净买入记录 累计加仓超550亿，美的集团净买入超11亿元",
            "features": {
                "keywords": [
                    "北向资金",
                    "净买入",
                    "美的集团"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "家电"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金追平年内最长净买入记录 累计加仓超550亿，美的集团净买入超11亿元",
                "Correlation": 4,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-09-01",
            "original_text": "沃森生物：公司新冠mRNA疫苗目前在海外获得墨西哥、印尼的三期临床试验批件",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA新冠疫苗",
                    "三期临床",
                    "墨西哥",
                    "印尼"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：公司新冠mRNA疫苗目前在海外获得墨西哥、印尼的三期临床试验批件",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-09-02",
            "original_text": "沃森生物：新冠mRNA疫苗正在开展三期临床试验 生产厂房已竣工交付",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA新冠疫苗",
                    "三期临床",
                    "生产厂房"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：新冠mRNA疫苗正在开展三期临床试验 生产厂房已竣工交付",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-09-06",
            "original_text": "A股融资融券日报：两融余额增加117.03亿元（9月6日）",
            "features": {
                "keywords": [
                    "A股",
                    "融资融券",
                    "两融余额"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额增加117.03亿元（9月6日）",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2022-01-01",
            "original_text": "沃森生物：公司二价HPV疫苗预计2022年可实现生产上市",
            "features": {
                "keywords": [
                    "沃森生物",
                    "二价HPV疫苗",
                    "生产上市"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：公司二价HPV疫苗预计2022年可实现生产上市",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]